TScan Therapeutics, Inc. (TCRX): 4 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Dec 23, 2025 | Lynx1 Capital Management LP TenPercentOwner | 161,801 | $0.90 | $145.6K | no history |
| May 21, 2025 | Lynx1 Capital Management LP TenPercentOwner | 2,588,794 | $1.20 | $3.1M | no history |
| Dec 16, 2024 | Nichols Weston TenPercentOwner | 131,800 | $2.93 | $385.7K | no history |
| Nov 19, 2024 | Nichols Weston TenPercentOwner | 947 | $4.34 | $4.1K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.